English
Home > Products > 166108-71-0

China 166108-71-0 Factory

Gaining purchaser gratification is our firm's intention eternally. We will make wonderful endeavours to build new and top-quality merchandise, satisfy your exclusive needs and provide you with pre-sale, on-sale and after-sale products and services for 166108-71-0,CAS NO 166108-71-0,Semaglutide intermediate,Semaglutide advance intermediate,[2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic, Our final goal is "To try the best, To be the Best". Please feel free to contact with us if you have any requirements.
166108-71-0, Our items have won an excellent reputation at each of the related nations. Because the establishment of our firm. now we have insisted on our production procedure innovation together with the most recent modern day managing method, attracting a sizable quantity of talents within this industry. We regard the solution good quality as our most vital essence character.

Related Products

Hot Products

  • 4-Chloro-3-nitrobenzonitrile

    4-Chloro-3-nitrobenzonitrile

    Product Name:4-Chloro-3-nitrobenzonitrile
    Molecular Formula:C7H3ClN2O2
    Molecular Weight:182.56
    CAS Registry Number:939-80-0
  • 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole

    5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole

    Product Name:5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole
    Molecular Formula:C11H9N3S
    Molecular Weight:215.27
    CAS Registry Number:172152-53-3
  • Ertapenem Side Chain

    Ertapenem Side Chain

    Product Name:Ertapenem Side Chain
    CAS No:202467-69-4
    Manufacture site:Ruyu
    Spec:In-house
    Batch size:200kg
    Annual capacity:50mt
  • Magnesium 3-hydroxybutyrate

    Magnesium 3-hydroxybutyrate

    Product Name:Magnesium 3-hydroxybutyrate
    Molecular Formula:C4H10MgO3
    Molecular Weight:130.43
    CAS Registry Number:163452-00-4
  • cis-Octahydroisoindole

    cis-Octahydroisoindole

    Product Name:cis-Octahydroisoindole
    Molecular Formula:C8H15N
    Molecular Weight:125.21
    CAS Registry Number:1470-99-1/21850-12-4
  • (S)-3-(4-(2-Chloro-5-Iodobenzyl)Phenoxy)-Tetrahydrofuran

    (S)-3-(4-(2-Chloro-5-Iodobenzyl)Phenoxy)-Tetrahydrofuran

    Product Name:(S)-3-(4-(2-Chloro-5-Iodobenzyl)Phenoxy)-Tetrahydrofuran
    CAS NO:915095-94-2
    Molecular Formula:C17H16ClIO2
    Formula Weight:414.67
    Usage:Empagliflozin Intermediates​
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 166108-71-0

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept